In tumor-bearing mice, the cytotoxicity ability of CD8+ T lymphocytes was discovered to be inhibited due to elevated ROS levels in immature myeloid cells generated from these animals compared to tumor-free animals (172). This evidence concerns the gene CD8A and neoplasm.